每年出版 6 期
ISSN 打印: 1040-8401
ISSN 在线: 2162-6472
Indexed in
Role of CD38 Expression in Diagnosis and Pathogenesis of Chronic Lymphocytic Leukemia and Its Potential as Therapeutic Target
摘要
CD38 is widely accepted as a marker for unfavorable prognosis in chronic lymphocytic leukemia (CLL). Nevertheless, its direct contribution to the disease pathogenesis is not very well understood. Recent data indicate that CD38 may promote CLL pathogenesis by enhancing proliferation in synergy with B-cell receptor (BCR) signaling and by supporting migration and homing of CLL cells to secondary lymphoid organs, where the malignant cells receive support from the tumor microenvironment. CD38 may also contribute to a suppressed anticancer immune response through the production of tolerogenic compounds. This review first shortly summarizes the biology, expression, and function of CD38 in general and in CLL cells in more detail. Next, the current literature and open questions regarding a direct contribution of CD38 to CLL pathogenesis are critically reviewed. Finally, I discuss the potential of CD38 as therapeutic target in light of its possible roles in CLL and the promising results of clinical trials with CD38 antibodies in multiple myeloma (MM)
-
Aebisher David, Bartusik Dorota, Tabarkiewicz Jacek, Laser flow cytometry as a tool for the advancement of clinical medicine, Biomedicine & Pharmacotherapy, 85, 2017. Crossref
-
Bürgler Simone, Malignant Interaction between B Cells and T Helper Cells, in Lymphocyte Updates - Cancer, Autoimmunity and Infection, 2017. Crossref
-
Berke Menteşe İlay, Yegin Zeynep Arzu, Gökçen Sanem, Özkurt Zübeyde Nur, Yağcı Münci, Prognostic Significance of Serum BAFF, APRIL, TACI and BCMA Levels in Chronic Lymphocytic Leukemia, Indian Journal of Hematology and Blood Transfusion, 35, 2, 2019. Crossref
-
Traxel Sabrina, Schadt Linda, Eyer Tatjana, Mordasini Vanessa, Gysin Claudine, Munthe Ludvig A., Niggli Felix, Nadal David, Bürgler Simone, Bone marrow T helper cells with a Th1 phenotype induce activation and proliferation of leukemic cells in precursor B acute lymphoblastic leukemia patients, Oncogene, 38, 13, 2019. Crossref
-
Qian Yisong, Chen Chuqiao, Ma Leliang, Wang Ziwei, Wang Ling-Fang, Zuo Li, Yang Yaqin, Huang Xiang, Jiang Meixiu, Wang Xiaolei, Shi Huidong, Fu Mingui, Deng Ke-Yu, Xin Hong-Bo, CD38 Deficiency Promotes Inflammatory Response through Activating Sirt1/NF-κB-Mediated Inhibition of TLR2 Expression in Macrophages, Mediators of Inflammation, 2018, 2018. Crossref
-
Li Hai-Long, Lee Jae-Rin, Hahn Myong-Joon, Yang Jun-Mo, Meng Fan-Guo, Wu Jia-Wei, Park Yong-Doo, The omics based study for the role of superoxide dismutase 2 (SOD2) in keratinocytes: RNA sequencing, antibody-chip array and bioinformatics approaches, Journal of Biomolecular Structure and Dynamics, 38, 10, 2020. Crossref
-
Konen Jessica M., Fradette Jared J., Gibbons Don L., The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors, Cells, 9, 1, 2019. Crossref
-
Ng Harry Ho Man, Lee Ren Yuan, Goh Siting, Tay Isabel Shu Ying, Lim Xinru, Lee Bernett, Chew Valerie, Li Huihua, Tan Benedict, Lim Sherlly, Lim Jeffrey Chun Tatt, Au Bijin, Loh Josh Jie Hua, Saraf Sahil, Connolly John Edward, Loh Tracy, Leow Wei Qiang, Lee Joycelyn Jie Xin, Toh Han Chong, Malavasi Fabio, Lee Ser Yee, Chow Pierce, Newell Evan W, Choo Su Pin, Tai David, Yeong Joe, Lim Tony Kiat Hon, Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma, Journal for ImmunoTherapy of Cancer, 8, 2, 2020. Crossref
-
Peng Yu Zhong, Yang Li Jun, Lo Hang Hong, Law Betty Yuen Kwan, Wong Vincent Kam Wai, Tumor Therapeutic Modes, in New Nanomaterials and Techniques for Tumor-targeted Systems, 2020. Crossref
-
Matveeva Olga V., Shabalina Svetlana A., Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy, Cancers, 12, 12, 2020. Crossref
-
Sciacchitano Salvatore, De Vitis Claudia, D’Ascanio Michela, Giovagnoli Simonetta, De Dominicis Chiara, Laghi Andrea, Anibaldi Paolo, Petrucca Andrea, Salerno Gerardo, Santino Iolanda, Amodeo Rachele, Simmaco Maurizio, Napoli Christian, Tafuri Agostino, Di Napoli Arianna, Sacconi Andrea, Salvati Valentina, Ciliberto Gennaro, Fanciulli Maurizio, Piaggio Giulia, de Latouliere Luisa, Ricci Alberto, Mancini Rita, Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies, Journal of Translational Medicine, 19, 1, 2021. Crossref
-
Morandi Fabio, Horenstein Alberto Leonardo, Malavasi Fabio, The Key Role of NAD+ in Anti-Tumor Immune Response: An Update, Frontiers in Immunology, 12, 2021. Crossref
-
Polyakova Yulia V., Zavodovsky Boris V., Sivordova Larisa E., Akhverdyan Yuri R., Zborovskaya Irina A., Visfatin and Rheumatoid Arthritis: Pathogenetic Implications and Clinical Utility, Current Rheumatology Reviews, 16, 3, 2020. Crossref
-
Gade Padmaja, Kimball Amy S., DiNardo Angela C., Gangwal Priyamvada, Ross Douglas D., Boswell H. Scott, Keay Susan K., Kalvakolanu Dhananjaya V., Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-β , Journal of Biological Chemistry, 291, 42, 2016. Crossref
-
Wu Lan, Seung Edward, Xu Ling, Rao Ercole, Lord Dana M., Wei Ronnie R., Cortez-Retamozo Virna, Ospina Beatriz, Posternak Valeriya, Ulinski Gregory, Piepenhagen Peter, Francesconi Elisa, El-Murr Nizar, Beil Christian, Kirby Patrick, Li Aiqun, Fretland Jennifer, Vicente Rita, Deng Gejing, Dabdoubi Tarik, Cameron Beatrice, Bertrand Thomas, Ferrari Paul, Pouzieux Stéphanie, Lemoine Cendrine, Prades Catherine, Park Anna, Qiu Huawei, Song Zhili, Zhang Bailin, Sun Fangxian, Chiron Marielle, Rao Srinivas, Radošević Katarina, Yang Zhi-yong, Nabel Gary J., Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation, Nature Cancer, 1, 1, 2020. Crossref
-
Eggers Marie, Rühl Felix, Haag Friedrich, Koch-Nolte Friedrich, Nanobodies as probes to investigate purinergic signaling, Biochemical Pharmacology, 187, 2021. Crossref
-
Eichhoff Anna Marei, Börner Kathleen, Albrecht Birte, Schäfer Waldemar, Baum Natalie, Haag Friedrich, Körbelin Jakob, Trepel Martin, Braren Ingke, Grimm Dirk, Adriouch Sahil, Koch-Nolte Friedrich, Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors, Molecular Therapy - Methods & Clinical Development, 15, 2019. Crossref